ClinicalTrials.gg
DrugRead study by study

Ipatasertib clinical trials

Also written GDC-0068 and RG7440.

studies test it
53
open now
6
in phase 3
5
first study started
2010
ClinicalTrials.gov finds 57 studies for ipatasertib. How that becomes 53 hereChecked on ClinicalTrials.gov

Every study that search finds has been read, to see whether and how it gives ipatasertib. Its counts are asked again every night. How drug pages count

  1. 57Found by its intervention search · See all 57 hereIt also reads titles, arm labels, keywords and descriptions, and counts the drug’s other names. Of these, 54 name it in an intervention entry. The counts it shows beside each synonym overlap: a study writing two names counts under both.
  2. 57Give ipatasertib to participants
  3. −4Give it beside what is tested
  4. 53Test it: the count on this site

Get an email when these change. Save the ipatasertib studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Ipatasertib
45
RO5532961, GDC-0068
2
Ipatasertib (capsule)
2
Ipatasertib (tablet)
2

Development codes

GDC-0068
20
RG7440
12
RO5532961
4

Studies by the year they started

53 studies that test it; most in 2021 (10)

Studies that test ipatasertib, by start year
YearStudies
20101
20111
20122
20132
20142
20154
20176
20186
20196
20205
202110
20225
20233

Who runs them

Industry 28 · Other 25

Hoffmann-La Roche (16) · Genentech, Inc. (12) · National Cancer Institute (NCI) (7) · Queen Mary University of London (2) · Canadian Cancer Trials Group (2) · Massachusetts General Hospital (1) · Royal Marsden NHS Foundation Trust (1) · Institute of Cancer Research, United Kingdom (1)

Often tested with

Tested in the same studies.

Atezolizumab (9) · Inavolisib (8) · Bevacizumab (7) · Paclitaxel (6) · Ado-Trastuzumab Emtansine (5) · Cobimetinib (5) · Carboplatin (4) · Pertuzumab (4)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 5

Studies that test ipatasertib.

Studies

Open first, then newest update. How each study uses ipatasertib has had a first review, but it may not be perfect: check the study record before relying on it for anything important, and report a problem from its row. Some give it without naming it in an intervention entry: those were found by reading the record.

Testing it · 53

See all 53 studies that test ipatasertib →

Tested on its own · 7 — no other medicine in its arm
Tested with established drugs · 19 — they are given beside it
Tested in a combination · 27 — another drug in the study is under test too

Showing 20 of 27. See all 27 →

One option of several · 4 — a test or a strategy chooses among drugs

Codes

What other systems call ipatasertib · ClinicalTrials.gg INT006352

  • MeSH (NLM) C583616ipatasertibConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 524Y3IB4HQIPATASERTIBConfirmed FDA, NLM, Wikidata
  • Wikidata Q27078088ipatasertibConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C91072IpatasertibOne source FDA
  • DrugBank DB11743One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.

Start the discussion